Immunohematology Market Product - Analyzers (Automatic and Semi-automatic/Nonautomatic), Reagents; Application - Blood Typing, Antibody Screening; End use - Hospitals, Academic and Research Institutes, Diagnostic and Reference Laboratories, Blood Banks - Forecast 2017-2025
Table of Content Sr. No. Chapter1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Chapter 15 Content Preface Assumptions and Research Methodology Executive Summary Market Overview Market Dynamics Immunohematology Market Analysis, by Product Immunohematology Market Analysis, by Application Immunohematology Market Analysis, by End-user Immunohematology Market Analysis, by Region North America Immunohematology Market Analysis Europe Immunohematology Market Analysis Asia Pacific Immunohematology Market Analysis Latin America Immunohematology Market Analysis Middle East & Africa Immunohematology Market Analysis Company Profiles
Immunohematology Market: Snapshot Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients. Major companies operating in the immunohematology market and profiled in the report are Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc.
Reports Highlights global immunohematology market was valued at US$ 1,462.1 Mn in 2016 and is projected to expand at a CAGR of 3.5% from 2017 to 2025 to reach value of US$ 1,991.8 Mn by 2025. Advancements in the immunohematology technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen antibody interaction, facilitating improvement in the compatibility reaction between the donor s blood and the recipient s blood. Increasing disposable income, rising health care awareness, and developing health care infrastructure have led to steady rise in the demand for better diagnosis and treatment measures in these countries. The global immunohematology market has been segmented in terms of product, application, end-user, and geography. 2019 Transparency Market Research, All Rights Reserved Request Sample
To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY 12207, United States Tel: +1-518-618-1030 T H A N K Y O U